Log in to save to my catalogue

Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients w...

Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients w...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8499934

Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study

About this item

Full title

Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study

Publisher

England: Oxford University Press

Journal title

Clinical kidney journal, 2022-01, Vol.15 (1), p.79-94

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

ABSTRACT
Background
The effect of renin–angiotensin system (RAS) blockade either by angiotensin-converting enzyme inhibitors (ACEis) or angiotensin-receptor blockers (ARBs) on coronavirus disease 2019 (COVID-19) susceptibility, mortality and severity is inadequately described. We examined the association between RAS blockade and COVID-19 diag...

Alternative Titles

Full title

Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8499934

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8499934

Other Identifiers

ISSN

2048-8505

E-ISSN

2048-8513

DOI

10.1093/ckj/sfab161

How to access this item